GENELUX Corp — Director's Dealing 2025

Dec 12, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GENELUX Corp (GNLX)
CIK: 0001231457
Period of Report: 2025-08-21

Reporting Person: Yu Yong (SVP, Clinical Development)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-08-21	Common Stock	S	3219	$3.3574	Disposed	146817	Direct
2025-11-17	Common Stock	S	973	$5.3694	Disposed	145844	Direct

Footnotes

F1: Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units.

F2: The total shown in Column 5 takes into account the transactions reported on Form 4 filed on August 29, 2025.